VKTX
VKTX
NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$32.37
+1.99 (+6.55%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 23 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +110.7% upside
Low Target $46.84
Average Target $68.21
High Target $80.11
Current Price $32.37
Current
$32.37
Target
$68.21
$46.84 $68.21 avg $80.11
Scenario Analysis
Bear Case
$46.84
44.7%
Low target
Base Case
$68.21
+110.7%
Avg target
Bull Case
$80.11
+147.5%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$43.15
-25.0% from high
52-Week Low
$22.96
+41.0% from low
50-Day SMA
$32.83
-1.4% vs SMA
200-Day SMA
$31.34
+3.3% vs SMA
RSI (14)
52.7
Neutral
Target vs 52W High
$68.21
+58.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%